Search
Ascendis Pharma A/S
ASNDAdd to Watchlist
230.830USD
-0.320-0.14%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
14.31BMarket Cap
33.26P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%
By RegionUSD
Name
Revenue
Proportion
North America
546.39M
75.87%
Europe
108.05M
15.00%
Rest of world
52.80M
7.33%
Denmark
12.90M
1.79%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%
